Document Type : Original Research


1 Dept. of Oral and Maxillofacial Pathology, Dental school, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 Shahrekord University of Medical Sciences, Shahrekord, Iran


Background & objective: Changes in submucosal vascularization and inflammation, determined by immunohistochemistry staining, were shown to be correlated with the development of dysplasia and invasiveness of epithelial cells in premalignant and malignant lesions. This study evaluated changes in sections routinely stained with Hematoxylin and Eosin (H&E) in order to investigate vascular density and intensity of inflammatory cells infiltration during the progression of oral leukoplakia with mild dysplasia to Squamous Cell Carcinoma (SCC).The aim of the research was to determine whether changes in sub-mucosal vascularity and inflammatory infiltration of leukoplakia in routine H&E-stained sections could contribute to the assessment of severity of the lesion.
Methods: In this cross-sectional, comparative and descriptive study, vascular density and inflammation intensity of 125 available samples of H&E-stained sections, consisting of 35 cases of mild and moderate dysplasia, 38 severe dysplasia and carcinoma in situ, and 52 SCC, were investigated. To analyze the data, chi-square test, Mann-Whitney test, Kruskal-Wallis test, Tukey’s post hoc test, and cumulative ordinal logistic regression were conducted.
Results: There was a significantly higher vascular density in cases with severe dysplasia, in situ carcinoma, and SCC compared to those with mild to moderate dysplasia (P<0.0001). However, the difference in vascularity was not statically significant between severe dysplasia, carcinoma in situ, and SCC (P=0.78). Intensity of inflammatory cells infiltration in the underlying connective tissue was significantly different among the three groups (P<0.0001), and the highest intensity of inflammatory cells infiltration was seen in the SCC group.
Conclusions: Increased submucosal vascularization and inflammatory cells infiltration can contribute further to predicting more aggressive epithelial dysplasia.


Main Subjects

1. Warnakulasuriya S, Johnson NW, Van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007; 36:575-580.
2. Regezi JA, Sciubba JJ, and Jordan RCK. Oral Pathology. 6th ed. Philadelphia USA: Elsevier Sunders. 2012: Chap. 3. 80-113.
3. Abbas NF, El-Sharkawy SL, Abbas EA, El-Shaer MAM. Immunohistochemical study of p53 and angiogenesis benign and preneoplastic oral lesions and oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral RadiolEndod 2007; 103:385-90.
4. Gandolfo M, Keszler A, Lanfranchi H, Itoiz ME. Increased subepithelial vascularization and VEGF expression reveal potentially malignant changes in human oral mucosa lesions. Oral Surg Oral Med Oral Pathol Oral RadiolEndod 2011; 111(4): 486-493.
5. Michailidou EZ, Markopoulos AK, Antoniades DZ. Mast cells and angiogenesis in oral malignant and premalignant lesions, Open Dent J 2008; 2:126-132.
6. Aromando RF, Raimondi AR, Perez MA, Trivillin VA, Schwint AE, Itoiz M, Angiogenesis in potentially malignant lesions and carcinomas during experimental oral carcinogenesis:a preliminary study in the hamster cheek pouch. Anticancer Res 2014; 34(11):6381-6388.
7. Jin Y, Tipoe GL, White FH, Yang L. A quantitative investigation of immunocytochemically stained blood vessels in normal, benign, premalignant and malignant human oral cheek epithelium. Virchows Arch 1995; 427: 145-151.
8. Ribatti D, Crivellato E. Mast cells, angiogenesis and tumour growth. BiochimBiophysActa 2012; 1822: 2–8.
9. Macluskey M, Chandrachud LM, Pazouki S, Green M, Chisholm DM, Ogden GR, Schor SL, Schor AM. Apoptosis, proliferation and angiogenesis in oral tissues possible relevance to tumour progression. J Pathol 2000; 191(4): 368-375.
10. Pazouki S, Chisholm DM, Adi MM, Carmichael G, Farquharson G, Ogden GR, Schor SL, Schor AM. The association between tumour progression and vascularity in the oral mucosa. J Pathol 1997; 183(1): 39-43.
11. Harris MK, Oral Cancer: Causes, Diagnosis and Treatment. New York. Nova Science Publishers Inc. 2011: 253-270.
12. Loening T, Broemel H, Becker WM, Otto HF. Identification of inflammatory cell phenotypes in human oral carcinomas by means of monoclonal antibodies. Arch Oral Biol 1983; 28(12): 1093–1100.
13. Gannot G, Gannot I, Vered H, Buchner A, Keisari Y. Increase in immune cell infiltration with progression of oral epithelium from hyperkeratosis to dysplasia and carcinoma. Brit J Cancer 2002; 86: 1444-1448.
14. Hamidi S, Salo T, Kainulainen T, Epstein J, Lerner K, Larjava H.Expression of avb6 integrin in oral leukoplakia. Brit J Cancer 2000; 82(8): 1433–1440.
  15. Syafriadi M, Cheng J, Jen KY, Ida-Yonemochi H, Suzuki M, Saku T. Two-phase appearance of oral epithelial dysplasia resulting from focal proliferation of parabasal cells and apoptosis of prickle cells. J Oral Pathol Med 2005; 34: 140–9.
16. Manchanda A, Shetty DC. Reproducibility of grading systems in oral epithelial dysplasia. Med Oral Patol Oral Cir Bucal 2012; 17(6): 935-942.
17. JalayerNaderi N, Semyari H, Elahinia Z. The impact of smoking on gingiva: a histopathological study. Iran J Pathol. 2015; 10(3): 214-220.
18. Gomes-filho J, Duarte P, Oliveria C, Watanabe S, Simonetti C. Tissue reaction to a triantibiotic paste used for endodontic self-generation of nonvital immature permanent teeth. J Endod 2012; 38(1):91-95.
19. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420: 860–867.
20. Yu JL, Rak JW. Inflammatory and immune cells in tumor angiogenesis and arteriogenasis. Breast Cancer Res 2003; 5: 83-8.
21. Mor F, Quintana F J., Cohan I R. Angiogenesis-Inflammation cross talk: VEGF is secreted by activated T cells and induces Th1 polarization. Journal of immunology, 2004; 172:4618-4623.